WNT5A and fatty liver disease: In line, it has been shown that Wnt5a induces C‐Jun N‐terminal kinase activation,47 which interferes with insulin signalling in the liver47, 48 suggesting that the non‐canonical Wnt pathway may contribute to hepatic steatosis, MASLD and MASH.47